RA DeFronzo, T Okerson, P Viswanathan, X … - Current Medical Research and Opinion®, 2008 - informahealthcare.com Methods: This double-blind, randomized cross-over, multi-center study was
conducted in metformin-treated T2D patients: 54% female; BMI: 33 ± 5 kg/m 2 ;
HbA 1c : 8.5 ± 1.2%; 2-h PPG: 245 ± 65 mg/dL. Patients received exenatide ... Cited by 26 - Related articles - All 6 versions
VA Gault, BD Kerr, N Irwin, PR Flatt - Biochemical Pharmacology, 2008 - Elsevier Glucose-dependent insulinotropic polypeptide has been proposed as a potential
therapeutic for type 2 diabetes, however, efforts to bring forward this drug
have been hindered due to its short circulating half-life. We have adopted ... Cited by 6 - Related articles - All 4 versions
- ►endojournals.org A Maida, JA Lovshin, LL Baggio, DJ Drucker - Endocrinology, 2008 - Endocrine Soc The proglucagon gene gives rise to multiple peptides that play diverse roles in
the control of energy intake, gut motility, and nutrient disposal. Glucagon-like
peptide-1 (GLP-1), a 30-amino-acid peptide regulates glucose homeostasis ... Cited by 4 - Related articles - All 3 versions
MM Sachdeva, DA Stoffers - Molecular Endocrinology, 2009 - Endocrine Soc Type 2 diabetes results from pancreatic ß-cell failure in the setting of
insulin resistance. This model of disease progression has received recent
support from the results of genome-wide association studies that identify ... Cited by 2 - Related articles - All 3 versions
- ►endojournals.org [PDF] H Duez, AC Smith, C Xiao, A Giacca, L Szeto, … - Endocrinology, 2008 - Endocrine Soc Page 1. 1 Acute DPP-4 Inhibition rapidly Enhances Insulin-mediated
Suppression of Endogenous Glucose Production in Mice Hélène ... Cited by 1 - Related articles
F INGESTION - Endocrinology - glucagon.com The proglucagon gene gives rise to multiple peptides that play diverse roles in
the control of energy intake, gut motility, and nutrient disposal. Glucagon-like
peptide-1 (GLP-1), a 30-ami- no-acid peptide regulates glucose homeostasis ... Related articles - View as HTML
- ►glucagon.com [PDF] H Duez, AC Smith, C Xiao, A Giacca, L Szeto, … - Endocrinology, 2009 - Endocrine Soc Pharmacological approaches that enhance incretin action for the treatment of
type 2 diabetes mellitus have recently been developed, ie. injectable
glucagon-like peptide-1 receptor (GLP-1R) agonists with prolonged plasma ... Related articles - All 3 versions
G Musso, R Gambino, G Pacini, F De Michieli … - American Journal of Clinical Nutrition, 2009 - Am Soc Nutrition ABSTRACT Background: Genetic and acquired mechanisms underlying the
associationofnonalcoholicfattyliverdisease(NAFLD)withdiabetes are unknown.
Glucose-dependent insulinotropic polypeptide (GIP) was recently linked to ... Related articles - All 4 versions
L Simonsen, S Pilgaard, C Orskov, B … - Diabetes, Obesity and Metabolism, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Related articles - All 4 versions
